Trials / Completed
CompletedNCT03232268
HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at evaluating the safety of an approach based on HLA-mismatched Microtransplantation without immunosuppressive treatment in patients With myeloid hemopathies who are ineligible to conventional allograft
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HLA-mismatched microtransplantation | 3 administrations of hematopoietic stem cells without immunosupression |
Timeline
- Start date
- 2018-03-09
- Primary completion
- 2026-01-07
- Completion
- 2026-01-07
- First posted
- 2017-07-27
- Last updated
- 2026-03-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03232268. Inclusion in this directory is not an endorsement.